Introduction {#s1}
============

Neuronal plasticity and memory formation require changes in gene expression that are triggered by synaptic activity. The nature and organization of this response is the subject of intense research, and a number of transcription factors (TF) have been identified in recent years as necessary for long-term memory consolidation and storage. The Ca^2+^/cAMP response element-binding protein (CREB) was initially identified as the main interlocutor in the dialogue between the synapse and the nucleus [@pone.0053848-Kandel1]. Later studies revealed the complexity of this process and implicated other transcription factors, including the serum response factor SRF [@pone.0053848-Ramanan1], MEF2 [@pone.0053848-Flavell1] and Npas4 [@pone.0053848-Lin1]. The availability of efficient methods for gene expression analysis has also contributed with a large collection of mRNAs, possible targets of these TF, whose expression is modulated by activity and experience [@pone.0053848-Kim1], [@pone.0053848-Benito1].

The large number of potential targets for these factors does not facilitate a model that clarifies how TF establish a coordinated response and regulate transcription for efficient remodeling of neuronal connections. The description of a 100 bp cis-regulatory enhancer element containing a cluster of CREB, MEF2 and SRF binding sites suggests a mechanism that might help to explain the selectivity and coordination of the activity-dependent transcriptional response. This sequence, termed SARE, was identified in the gene that encodes the activity-regulated cytoskeleton-associated protein (Arc) [@pone.0053848-Kawashima1]. The SARE sequence is conserved in mammalian Arc regulatory regions; it is sufficient to drive a rapid transcriptional response following synaptic activation and to reproduce, both *in vitro* and *in vivo*, the endogenous Arc activation pattern [@pone.0053848-Kawashima1]. Despite the novelty and potential repercussion of this finding, the study restricted the description of this sequence to the *Arc* gene and did not determine whether SARE appear in the regulatory regions of other genes, or the specificity of this sequence to the nervous system. We studied the broader implication of SARE sequences in the context of the response to neuronal activity, and validated SARE analysis as able to identify elements of synaptic plasticity. Using the *in silico* tool SynoR [@pone.0053848-Ovcharenko1], we analyzed the SARE sequences conserved in the mammalian genome. Comparison of mouse and human genome sequences showed enrichment in conserved SARE clusters in the regulatory regions of genes that are expressed specifically in neural tissues, that are involved in neural development and homeostatic maintenance, and that encode mRNA targeted by FMRP. These data support the concept that SARE sequences are true transcriptional regulatory elements, responsible for the coordinated response of TF that convey information from the postsynaptic compartment to the nucleus. These findings might contribute to understanding the genetic causes of mental diseases linked to neuronal plasticity.

Results and Discussion {#s2}
======================

We used SynoR to study the possible relationship between the SARE regulatory region and genes related to the nervous system [@pone.0053848-Ovcharenko1], specifically those involved in synaptic activity and mental processes. We sought sequence regions containing clusters of the consensus binding sites for CREB, MEF2 and SRF ([Fig. 1A](#pone-0053848-g001){ref-type="fig"}) in the human genome, and compared them to the mouse genome to identify conserved sequences. Based on these criteria, we identified 887 genetic regions containing SARE sequences ([Table S1](#pone.0053848.s001){ref-type="supplementary-material"} and data deposited in the SynoR tool, ID: s1219104005847). The SARE regions are assigned to the gene(s) of which they form part or to which they are proximal, and are classified as intergenic, intronic, utr (untranslated), cds (coding sequence), or promoter, depending on their position within the gene ([Table S1](#pone.0053848.s001){ref-type="supplementary-material"} and [Fig. 1B](#pone-0053848-g001){ref-type="fig"}). Control searches for clusters containing combinations of other unrelated TFBS yield significantly less number of regions and were not enriched in neural biological functions ([Fig. 1C](#pone-0053848-g001){ref-type="fig"} and Experimental Procedures). The original SARE sequence of the Arc promoter is not identified in our search because it contains only half of the CREB binding site, and its MEF2 binding sequence shows 2 nucleotide mismatches compared to the consensus [@pone.0053848-Kawashima1]. Binding site predictions for individual TF using matrix analysis can be conducted with the Match tool of TRANSFAC. We have validated the presence of the SARE cluster in more than ten of our candidates manually using this tool. These include *ATF3*, *CUX1*, *CUX2*, *FOXP1, FOXP2, HOMER1*, *LMPDH2*, *NRG1, NPAS4. NR4A1, PLXNA4 and SEMA6A.* Similarly, there might be additional SARE sequences not identified by this search because of the analysis procedure: it first identifies TFBS clusters in the human genome and subsequently searches for homology to this specific sequence in mice.

![SARE sequences are found in intergenic and intronic genetic regions.\
Scheme showing consensus TFBS for SARE sequence and the SARE sequenced found in the promoter of *SOX14* (top). For the SynoR search, random relative position of the three TFBS was permitted. Table shows the number and percentages of SARE sequences classified according to their position within the genes and the diagram represents the distribution of each category.](pone.0053848.g001){#pone-0053848-g001}

The analysis showed that SARE clusters were most abundant in intergenic and intronic regions ([Fig. 1](#pone-0053848-g001){ref-type="fig"}), potential areas for gene expression control. The list of SARE-containing genes showed genes with central roles in the nervous system such as NMDA (*Grin2a*, essential for excitatory synapses), *Robo2* (with major functions in axon guidance) and *Cutl/Cux2* (determinant for cerebral cortex layer II-IV) (examples in [Table 1](#pone-0053848-t001){ref-type="table"}). Classification of genes containing SARE sequences at the GO categories using Toppfun application *(* <http://toppgene.cchmc.org/> *"ToppFun")* indicated that the processes potentially affected by SARE regulation are clearly related to the nervous system ([Table S2](#pone.0053848.s002){ref-type="supplementary-material"}). This analysis yielded several enriched GO categories, out of 112 significantly enriched GO biological processes, 21 (18,75%) of them related to neural functions ([Table 2](#pone-0053848-t002){ref-type="table"}). All of these categories are specifically related to nervous system development and maintenance, and many showed significant greater enrichment than other categories ([Table 2](#pone-0053848-t002){ref-type="table"} and [Table S2](#pone.0053848.s002){ref-type="supplementary-material"}). In accordance with our hypothesis, this prevalence of neural functions supports potentially important, selective action of SARE-mediated mechanisms in the nervous system. Next, SARE containing genes were grouped into two main categories representing potential distal and proximal regulatory sequences: intergenic; and intragenic, cds, promoter and utr regions ([Table S2](#pone.0053848.s002){ref-type="supplementary-material"}) and GO analysis was performed separately with these two groups. Both groups showed similar enrichment in neural functions; therefore it did not favor proximal or distal regulatory regions as more relevant to plasticity.

10.1371/journal.pone.0053848.t001

###### SARE regulation affects several aspects of neuron function.

![](pone.0053848.t001){#pone-0053848-t001-1}

  Gene symbol                                                             Name                                   Human gene ID      Type
  -------------------------------------- ---------------------------------------------------------------------- --------------- ------------
  **Synaptogenesis-Plasticity**                                                                                                 
  SYNCRIP                                      synaptotagmin binding, cytoplasmic RNA interacting protein            10492          utr
  HDAC5                                                          histone deacetylase 5                               10014          utr
  HOMER1                                                      homer homolog 1 (Drosophila)                           9456         promoter
  KALRN                                                          kalirin, RhoGEF kinase                              8997           utr
  NCAM1                                                     neural cell adhesion molecule 1                          4684          intron
  NRG1                                                                neuregulin 1                                   3084          intron
  NRXN1                                                                neurexin 1                                    9378          intron
  SCN3A                                          sodium channel, voltage-gated, type III, alpha subunit              6328           utr
  SEPT7                                                                 septin 7                                      989           utr
  **Citoesqueletal-synaptic proteins**                                                                                          
  ANK3                                                   ankyrin 3, node of Ranvier (ankyrin G)                       288           utr
  CAMK1D                                             calcium/calmodulin-dependent protein kinase ID                  57118         intron
  MAP2K5                                               mitogen-activated protein kinase kinase 5                     5607          intron
  NR4A1                                             nuclear receptor subfamily 4, group A, member 1                  3164          intron
  RABGAP1L                                                RAB GTPase activating protein 1-like                       9910          intron
  RAPGEF2                                            Rap guanine nucleotide exchange factor (GEF) 2                  9693          intron
  RAPGEF6                                            Rap guanine nucleotide exchange factor (GEF) 6                  51735         intron
  RASSF8                                   Ras association (RalGDS/AF-6) domain family (N-terminal) member 8         11228          utr
  RASGEF1C                                                  RasGEF domain family, member 1C                         255426         intron
  RHOQ                                                     ras homolog gene family, member Q                         23433          utr
  **Axon guidance and maintenance**                                                                                             
  CRIM1                                        cysteine rich transmembrane BMP regulator 1 (chordin-like)            51232         intron
  DCC                                                       deleted in colorectal carcinoma                          1630          intron
  EPHB1                                                             EPH receptor B1                                  2047         promoter
  NRG1                                                                neuregulin 1                                   3084          intron
  PLCXD3                                  phosphatidylinositol-specific phospholipase C, X domain containing 3      345557         intron
  PLXNC1                                                               plexin C1                                     10154         intron
  PLXNA4                                                               plexin A4                                     91584         intron
  RGMA                                                        RGM domain family, member A                            56963       intergenic
  ROBO1                                        roundabout, axon guidance receptor, homolog 1 (Drosophila)            6091        intergenic
  SEMA6A                                        sema domain, TM and cytoplasmic domain, (semaphorin) 6A              57556        promoter
  **Transcription factors**                                                                                                     
  CUX1                                                            cut-like homeobox 1                                1523          intron
  CUX2                                                            cut-like homeobox 2                                23316         intron
  FOXP1                                                             forkhead box P1                                  27086         intron
  FOXP2                                                             forkhead box P2                                  93986         intron
  PAX6                                                                paired box 6                                   5080          intron
  PHOX2B                                                        paired-like homeobox 2b                              8929           utr
  RUNX2                                                   runt-related transcription factor 2                         860           utr
  SOX6                                                    SRY (sex determining region Y)-box 6                       55553         intron
  ZIC2                                                            Zic family member 2                                7546           utr
  ZNF292                                                        zinc finger protein 292                              23036          utr

Examples of genes containing SARE sequences according to function, extracted from the list of 827 genes identified.

10.1371/journal.pone.0053848.t002

###### Classification of SARE-containing genes at GO indicated significant enrichment of processes related to the nervous system.
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  GO: Biological Process                                                             
  ------------------------ ------------ -------------------------------------------- ----------
  2                         GO:0030182             neuron differentiation             1,76E-11
  4                         GO:0048699             generation of neurons              1,52E-10
  5                         GO:0022008                  neurogenesis                  2,28E-10
  9                         GO:0048812        neuron projection morphogenesis         2,87E-09
  10                        GO:0007409                  axonogenesis                  3,40E-09
  13                        GO:0048666               neuron development               6,43E-09
  16                        GO:0031175         neuron projection development          2,28E-08
  28                        GO:0007411                 axon guidance                  2,75E-07
  31                        GO:0007417       central nervous system development       3,49E-07
  45                        GO:0035295                tube development                9,04E-06
  58                        GO:0045664      regulation of neuron differentiation      1,27E-04
  73                        GO:0030900             forebrain development              1,74E-03
  74                        GO:0007420               brain development                1,75E-03
  83                        GO:0021772           olfactory bulb development           5,05E-03
  84                        GO:0031290      retinal ganglion cell axon guidance       5,46E-03
  87                        GO:0021889   olfactory bulb interneuron differentiation   6,39E-03
  91                        GO:0021988           olfactory lobe development           7,48E-03
  96                        GO:0007423           sensory organ development            1,29E-02
  97                        GO:0021537           telencephalon development            1,30E-02
  111                       GO:0001654                eye development                 4,50E-02
  112                       GO:0021891     olfactory bulb interneuron development     4,54E-02

The analysis yielded 112 significantly enriched GO biological processes. The table shows the 21 categories with significantly high fold enrichment that are related to nervous system development and maintenance. Rank indicates the position within the list of the total 112 when ordered from higher to lower enrichment. Neural functions are ranked in the higher positions.

The analysis of genes containing the SARE cluster appeared an appropriate approach for identification of mechanisms of homeostasis, plasticity and activity-dependent remodeling in the nervous system. This study disclosed a large number of genes known to participate in plasticity and synaptogenesis (examples in [Table 1](#pone-0053848-t001){ref-type="table"}); *Homer1* is an example in this category. *Homer* genes encode scaffolding proteins that bind Ca^2+^ signaling proteins and target them to their correct subcellular localization [@pone.0053848-Yuan1], [@pone.0053848-Worley1]; they are essential for dynamic regulation of the synapse, synaptic plasticity, and spatial learning [@pone.0053848-Sala1], [@pone.0053848-Tu1]. Coincident expression of experience-triggered Homer and Arc proteins is found in hippocampal and cortical neurons [@pone.0053848-Vazdarjanova1], which supports simultaneous activation, as predicted by our analysis. We also identified axonal guidance molecules ([Table 1](#pone-0053848-t001){ref-type="table"} and [Table S1](#pone.0053848.s001){ref-type="supplementary-material"}), including *PlxnA4* and its ligand *Sema6A* [@pone.0053848-Zhou1] as molecules potentially regulated by SARE. The semaphorin and plexin receptor families, together with neuropilins, are crucial during nervous system development and homeostasis, and mark the pathway for axon growth [@pone.0053848-Zhou1]. These proteins also control synaptogenesis, axon pruning, the density and maturation of dendritic spines and are implicated in a number of developmental, psychiatric and neurodegenerative disorders [@pone.0053848-Pasterkamp1]. As for the axon guidance cues, we found a number of genes that encode cytoskeletal remodeling molecules at the synapse ([Table 1](#pone-0053848-t001){ref-type="table"}). For example, ankyrins link integral membrane proteins to the underlying spectrin-actin cytoskeleton; they have key roles in activities such as cell motility, activation, proliferation, contact, and maintenance of specialized membrane domains. They might be involved in bipolar disorder and other mental alterations [@pone.0053848-Huang1].

Less anticipated were SARE-containing genes not previously implicated in plasticity or structural maintenance of the synapse; in this category, we found neuronal subtype-specific TF such as *Cux1* and *Cux2* [@pone.0053848-Cubelos1], *Zic2* [@pone.0053848-Herrera1] and *Sox6* [@pone.0053848-Azim1], [@pone.0053848-BatistaBrito1] ([Table 1](#pone-0053848-t001){ref-type="table"} and [Table S1](#pone.0053848.s001){ref-type="supplementary-material"}). Cux TF expression is restricted to neurons of layers II-III and IV of the cerebral cortex. During development, Cux regulate dendritic branching, spine morphogenesis and synapse maturation [@pone.0053848-Cubelos1]. Cux expression is maintained through adulthood, but nothing is yet known of their function in mature neurons. Whereas Cux functions could be associated with plasticity at the postsynaptic site [@pone.0053848-Cubelos1], Zic2 might act on the presynaptic terminal, as it is associated with axon development in retinal ganglion cells; Sox6, in turn, is described as essential for neuronal differentiation [@pone.0053848-Azim1], [@pone.0053848-BatistaBrito1]. These observations suggest that activity-dependent mechanisms act on pathways specific to neuronal subtypes.

To test the relevance of our findings and the predictive capability of our gene set to identify genes up-regulated upon neuronal activation we searched for experimental confirmation. Several studies of gene expression changes induced by neuronal activation have been reported and made useful available contributions. Many of them analyze the effects of the gabaergic inhibitor bicuculline to trigger neuronal excitatory response. We therefore compare the list of SARE containing genes with those of genes which expression was modify in studies analyzing the *in vivo* effects of infusion of bicuculline into the accessory olfactory bulb [@pone.0053848-Upadhya1]; *in vitr*o bicuculline treatment of cortical cells [@pone.0053848-Liu1]; and hippocampal neuronal cultures [@pone.0053848-Benito2]. This allowed us to extend our validation to several neuronal types. In all three cases, the comparison revealed a highly significant enrichment between the SARE containing genes and those up-regulated upon neuronal activation, but none or of lower statistical significance, when compared to the list of genes that are down-regulated ([Table 3](#pone-0053848-t003){ref-type="table"}). Several of the SARE genes, such as *Homer*, *Atf3*, *Klf6* and *Bdnf* are common to two or the three studies, and may represent a general pan-neuronal response, while unique ones might represent tissue-specific responses. These significant overlapping validate our results with external independent data. We next took the reverse approach and tested the predictive capability of our study by testing the expression of genes picked from our list upon neuronal activation. Cells from E18 mouse cortex were dissociated, neurons were cultivated and neuronal activity triggered using bicuculline [@pone.0053848-Kawashima1]. RNA was obtained and transcript expression of twelve SARE containing genes, including Arc, analyzed by using quantitative real time RT-PCR (Q-PCR) ([Fig. 2A](#pone-0053848-g002){ref-type="fig"}). Up-regulation of Arc gene demonstrated efficient neuronal activation and, also expected, the levels of the S-isoform of *Homer1* were increased [@pone.0053848-Bottai1], [@pone.0053848-Inoue1]. Six more genes showed up-regulation when neurons were activated. *Atf3*, *Impdh2*, and *Npas4* up-regulation in cortical cells was in agreement with our own analysis of the raw data obtained from gene expression arrays reported by other investigators [@pone.0053848-Liu1], and further confirmed our comparison with external sources ([Table 3](#pone-0053848-t003){ref-type="table"}). Interestingly, up-regulation of *Cux1*, *Cux2*, and *PlxnA4,* genes not suspected to be regulated by activity, again confirmed the predictive capacity of our study. Four genes, *Lmo4*, *Robo1*, *Robo2* and *Klf6* did not show significant changes. This can be ascribed to the almost certain possibility of a number of false positive in our list, to the fact that other splicing variants might be affected, or to the possibility that subsets of genes may respond differently depending on the stimulus that triggers neuronal response.

![Up-regulation of the mRNA of SARE containing genes and promoter activation in response to neuronal activity. A)\
*Upregulation of SARE identified candidates in primary cortical neurons.* Primary neurons from E18 cortex were cultivated for 16 days before triggering neuronal activation with 4AP/bicuculline. RNA was obtained and transcript expression of SARE containing genes analyzed by quantitative real time RT-PCR (Q-PCR). Expression of each gene is normalized to the expression in control cells. Arc up-regulation demonstrated efficient neuronal activation. \* indicates p\<0,5 \*\*\<0,1, \*\*\*\<0,05 (t-Student test). **B).** *Novel SARE sequences activate transcription in response to neuronal activity.* Mouse genomic sequence containing SARE regulatory regions (see below) corresponding to those identified for the *Cux1* and *Cux2* genes were cloned into the pGL4.23 luciferase vector (Promega). Neurons obtained from E18,5 cortex were co-transfected with the indicated firefly luciferase reporter construct and internal control Renilla luciferase plasmid at a ratio of 4∶1. Neuronal activity was trigered with 4AP/bicuculline before measuring transcription of the reporters. Relative expression of each reporter constructs was determined by normalizing the activity of each reporter to its activity on TTX treated neurons. Data represent mean and standar deviation of results obtained in three different experiments. \* indicates p\<0,01, \*\*\<0,001 (t-Student test).](pone.0053848.g002){#pone-0053848-g002}

10.1371/journal.pone.0053848.t003

###### The number of SARE containing genes is significantly enriched on genes up-regulated upon bicuculline triggering of neuronal activity.
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  Comparative analysis with reported studies                              
  -------------------------------------------- ------------- ------------ -------------
  \# of upregulated genes                       (211 genes)   (90 genes)   (229 genes)
                                                  *Atf3*        *Atf3*        *Arc*
                                                  *Bdnf*        *Bdnf*       *Atf3*
                                                  *Celf2*      *Edil3*       *Bdnf*
                                                  *Clic4*       *Erc2*     *C10orf140*
                                                  *Eif1*       *Inhba*      *Fbxo33*
                                                 *Epb41l1*      *Ism1*      *Homer1*
                                                  *Hdac5*      *Nkain2*     *Impdh2*
                                                  *Hdac9*       *Odz1*       *Kcnj2*
                                                 *Homer1*       *Pax1*       *Klf6*
  Up-regulated genes                              *Inhba*      *Ppfia2*      *Mex3b*
                                                  *Klf6*                     *Nefl*
                                                 *Lingo1*                    *Nhlh2*
                                                  *Lmo4*                     *Npas4*
                                                  *Nemf*                     *Nr4a1*
                                                 *Pcdh17*                  *Rasgef1b*
                                                  *Ppm1b*                 
                                                  *Rcan2*                 
                                                  *Smg7*                  
                                                 *Tsc22d2*                
  p-value                                        4,87E-05     0.00066422    0.003991
  \# of downregulated genes                     (36 genes)    (44 genes)   (23 genes)
                                                 *Bahcc1*      *Dock5*    
  Down-modulated genes                           *Ranbp2*      *Fam5b*    
                                                               *Slit3*    
                                                               *Trpc7*    
  p-value                                         0.20867      0.042004      0.46753

Comparative analysis of the list of SARE containing genes with three independent studies reporting mRNA changes in gene expression in the accessory olfactory bulb [@pone.0053848-Upadhya1]; cortical cells [@pone.0053848-Liu1]; and hippocampal neuronal cultures [@pone.0053848-Benito2]. The table shows the lists of the SARE genes that were found to be up-regulated (upper part), or down-modulated (lower part) in each study. P-values for random coincidence are shown. Not significance coincidence was observed when compared to genes that are down-regulated.

Next, the sequence corresponding to two of these SARE sequences were cloned upstream of a minimal promoter into vectors containing luciferase reporters to test their ability to activate transcription in response to neuronal activity. Cells from E18 mouse cortex were transfected with reporter constructs, neuronal activity triggered using bicuculline [@pone.0053848-Kawashima1], and luciferase activity compared to control tetrodotoxin (TTX) treated neurons. These experiments demonstrated that these novel identified SARE sequences replicate the promoter activity of the SARE sequence corresponding to the Arc gene and significantly increase transcription upon depolarization ([Fig. 2B](#pone-0053848-g002){ref-type="fig"}).

Our analyses thus point to overlooked pathways that might participate in activity-dependent regulatory mechanisms and, by extension, suggests the identification of genes potentially linked to mental diseases caused by plasticity defects [@pone.0053848-Luscher1], [@pone.0053848-Hoeffer1], [@pone.0053848-Walsh1]. This is the case of genes reported as candidates for autism in which we found SARE sequences, such as, *NRXN1* and 2 [@pone.0053848-Feng1], *FOXP1* [@pone.0053848-ORoak1], *FOXP2* [@pone.0053848-ORoak1], [@pone.0053848-MacDermot1], *GRID2* [@pone.0053848-Schaaf1], *KCNMA1* [@pone.0053848-Laumonnier1] and others (<http://gene.sfari.org>) [@pone.0053848-Basu1] (see [Table S1](#pone.0053848.s001){ref-type="supplementary-material"}).

Validation of our prediction nonetheless required evaluation of true enrichment of genes involved in cognitive dysfunction. Fragile X syndrome (FXS) is a well-characterized form of autism, caused by loss of function of the Fragile X mental retardation protein (FMRP), which regulates local translation and plasticity at pre- and postsynaptic sites [@pone.0053848-Walsh1], [@pone.0053848-Kelleher1]. Based on a recent extensive list of genes targeted by FMRP, from which the authors extract a stringent set of 842 reliable targets [@pone.0053848-Darnell1], we hypothesized that the list of SARE-regulated genes will be enriched in FMRP targets. Comparison of SARE-containing genes (including those containing SARE clusters at intergenic locations) with the stringent list of FMRP targets resulted in 70 genes common to both (8.5% overlap), an enrichment of biological relevance (p = 4.3909--13; see Methods) ([Table 4](#pone-0053848-t004){ref-type="table"}). The relationship between the SARE-containing genes and FMRP targets thus strongly supports SARE involvement in activity-dependent regulation. In addition, it suggests that mutations in SARE or SARE-containing genes and pathways can contribute to mental retardation, autism spectrum disorders and other psychiatric diseases.

10.1371/journal.pone.0053848.t004

###### FMRP targets containing SARE sequence genes.
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  FMRP targets containing SARE sequence                                               
  --------------------------------------- ----------------- -------- ---------------- ----------------------------------------------------------------------------
  *ANK3*                                       *Ank3*        11735     NM_146005.3                       ankyrin 3, node of Ranvier (ankyrin G)
  *APP*                                         *App*        11820     NM_007471.2                        amyloid beta (A4) precursor protein
  *ARID1B*                                    *Arid1b*       239985   NM_001085355.1                   AT rich interactive domain 1B (SWI1-like)
  *ATN1*                                       *Atn1*        13498     NM_007881.4                                     atrophin 1
  *ATP2A2*                                    *Atp2a2*       11938    NM_001110140.2            ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
  *ATXN1*                                      *Atxn1*       20238     NM_009124.5                                      ataxin 1
  *BAI1*                                       *Bai1*        107831    NM_174991.3                      brain-specific angiogenesis inhibitor 1
  *BCAN*                                       *Bcan*        12032     NM_007529.2                                      brevican
  *BIRC6*                                      *Birc6*       12211     NM_007566.2                        baculoviral IAP repeat-containing 6
  *CADPS*                                      *Cadps*       27062     NM_012061.3                         Ca++-dependent secretion activator
  *CTNND2*                                    *Ctnnd2*       18163     NM_008729.2                   catenin (cadherin-associated protein), delta 2
  *CUX1*                                       *Cux1*        13047     NM_009986.3                                cut-like homeobox 1
  *CUX2*                                       *Cux2*        13048     NM_007804.2                                cut-like homeobox 2
  *DIP2B*                                      *Dip2b*       239667    NM_172819.2              DIP2 disco-interacting protein 2 homolog B (Drosophila)
  *EPB41L1*                                  *Epb4.1l1*      13821    NM_001003815.2                  erythrocyte membrane protein band 4.1-like 1
  *FAM5B*                                  *6430517E21Rik*   240843    NM_207583.1                    family with sequence similarity 5, member B
  *FOXK2*                                      *Foxk2*       68837    NM_001080932.1                                forkhead box K2
  *GABBR1*                                    *Gabbr1*       54393     NM_019439.3                    gamma-aminobutyric acid (GABA) B receptor, 1
  *GNB1*                                       *Gnb1*        14688     NM_008142.3         guanine nucleotide binding protein (G protein), beta polypeptide 1
  *GRIK3*                                      *Grik3*       14807    NM_001081097.2                   glutamate receptor, ionotropic, kainate 3
  *HDAC5*                                      *Hdac5*       15184    NM_001077696.1                             histone deacetylase 5
  *HIPK2*                                      *Hipk2*       15258    NM_001136065.1                    homeodomain interacting protein kinase 2
  *HIPK3*                                      *Hipk3*       15259     NM_010434.1                      homeodomain interacting protein kinase 3
  *IDS*                                         *Ids*        15931     NM_010498.2                               iduronate 2-sulfatase
  *KALRN*                                      *Kalrn*       545156   NM_001164268.1                             kalirin, RhoGEF kinase
  *KCND2*                                      *Kcnd2*       16508     NM_019697.3         potassium voltage-gated channel, Shal-related subfamily, member 2
  *KCNH7*                                      *Kcnh7*       170738    NM_133207.2        potassium voltage-gated channel, subfamily H (eag-related), member 7
  *KCNMA1*                                    *Kcnma1*       16531     NM_010610.2               potassium large conductance calcium-activated channel
  *LINGO1*                                    *Lingo1*       235402    NM_181074.4                   leucine rich repeat and Ig domain containing 1
  *LRRC7*                                      *Lrrc7*       242274   NM_001081358.1                        leucine rich repeat containing 7
  *MAGI2*                                      *Magi2*       50791     NM_015823.2        membrane associated guanylate kinase, WW and PDZ domain containing 2
  *MFHAS1*                                    *Mfhas1*       52065    NM_001081279.1              malignant fibrous histiocytoma amplified sequence 1
  *MIB1*                                       *Mib1*        225164    NM_144860.2                          mindbomb homolog 1 (Drosophila)
  *MYT1L*                                      *Myt1l*       17933    NM_001093775.1                       myelin transcription factor 1-like
  *NCAM1*                                      *Ncam1*       17967    NM_001081445.1                        neural cell adhesion molecule 1
  *NFIX*                                       *Nfix*        18032    NM_001081981.1            nuclear factor I/X (CCAAT-binding transcription factor)
  *NPAS2*                                      *Npas2*       18143     NM_008719.2                           neuronal PAS domain protein 2
  *NRXN1*                                      *Nrxn1*       18189     NM_020252.2                                     neurexin 1
  *NRXN2*                                      *Nrxn2*       18190     NM_020253.2                                     neurexin 2
  *NRXN3*                                      *Nrxn3*       18191     NM_172544.3                                     neurexin 3
  *NTRK3*                                      *Ntrk3*       18213     NM_182809.2                   neurotrophic tyrosine kinase, receptor, type 3
  *ODZ2*                                       *Odz2*        23964     NM_011856.3                      odz, odd Oz/ten-m homolog 2 (Drosophila)
  *OGDH*                                       *Ogdh*        18293     NM_010956.3            oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide)
  *PCDH7*                                      *Pcdh7*       54216    NM_001122758.1                                protocadherin 7
  *PCDH9*                                      *Pcdh9*       211712   NM_001081377.1                                protocadherin 9
  *PHACTR1*                                   *Phactr1*      218194    NM_198419.3                         phosphatase and actin regulator 1
  *PLXNA4*                                    *Plxna4*       243743    NM_175750.3                                     plexin A4
  *PPARGC1A*                                 *Ppargc1a*      19017     NM_008904.1       peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
  *PRICKLE2*                                 *Prickle2*      243548   NM_001081146.1                         prickle homolog 2 (Drosophila)
  *PTCH1*                                      *Ptch1*       19206     NM_008957.2                           patched homolog 1 (Drosophila)
  *PTPRG*                                      *Ptprg*       19270     NM_008981.3                   protein tyrosine phosphatase, receptor type, G
  *PUM2*                                       *Pum2*        80913     NM_030723.1                           pumilio homolog 2 (Drosophila)
  *R3HDM2*                                    *R3hdm2*       71750     NM_027900.3                              R3H domain containing 2
  *RAPGEF2*                                   *Rapgef2*      76089    NM_001099624.2                 Rap guanine nucleotide exchange factor (GEF) 2
  *SASH1*                                      *Sash1*       70097     NM_175155.4                          SAM and SH3 domain containing 1
  *SLITRK5*                                   *Slitrk5*      75409     NM_198865.1                        SLIT and NTRK-like family, member 5
  *SMARCA2*                                   *Smarca2*      67155     NM_011416.2     SWI/SNF related, matrix associated, actin dependent regulator of chromatin
  *SMG1*                                   *2610207I05Rik*   233789   NM_001031814.1    SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans)
  *SPRED1*                                    *Spred1*       114715    NM_033524.2                     sprouty-related, EVH1 domain containing 1
  *TANC2*                                      *Tanc2*       77097     NM_181071.3       tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2
  *TCF4*                                       *Tcf4*        21413     NM_013685.2                               transcription factor 4
  *TRIO*                                       *Trio*        223435   NM_001081302.1                  triple functional domain (PTPRF interacting)
  *TRIP12*                                    *Trip12*       14897     NM_133975.4                       thyroid hormone receptor interactor 12
  *VPS13D*                                    *Vps13d*       230895   NM_001128198.1             vacuolar protein sorting 13 homolog D (S. cerevisiae)
  *ZEB2*                                       *Zeb2*        24136     NM_015753.3                        zinc finger E-box binding homeobox 2
  *ZNF365*                                    *Zfp365*       216049    NM_178679.2                              zinc finger protein 365
  *ZNF462*                                    *Zfp462*       242466    NM_172867.3                              zinc finger protein 462
  *ZNF521*                                    *Zfp521*       225207    NM_145492.3                              zinc finger protein 521
  *ZNF536*                                    *Zfp536*       243937    NM_172385.2                              zinc finger protein 536
  *ZNF827*                                    *Zfp827*       622675    NM_178267.3                              zinc finger protein 827

The list of genes identified as containing SARE sequences was compared to a list of 842 reliable FMRP targets. This resulted in an overlap of 70 genes common to both lists. This represent a significant enrichment of p = 4.39096.93e-13, far from the expected random distribution of coincidences between the genome and the mouse nervous system transcriptome (see Experimental Procedures).

Correct function of nervous system networks and subnetworks is possible thanks to the extraordinary spatial and temporal coordination of gene expression that is guided by the TF subset expressed by each neuronal population. Our findings suggest that cooperation between CREB, SRF, and MEF2 transcription factors at the SARE region is one of the precisely regulated mechanisms that govern the transcriptional program of activated neurons. This transcriptional cooperation might also apply to other TF to initiate an appropriate, specific transcriptional response in other biological processes. This study also highlights the value of the development and use of computational tools and databases for the comprehensive analysis of biological events. We identified a subset of genes whose transcription is potentially regulated by the SARE cluster after synaptic activation. Most of these genes are directly related to nervous system development and maintenance; several of them are reported at the synapse, some are mutated in human mental disorders, and many form part of FMRP-regulated mechanisms. The identification and functional analysis of SARE-containing genes provided here is thus a useful for implicating new candidate genes in plasticity, memory, and mental retardation, and suggests new approaches to the study of mental disorders in which synaptic activity might have a central role.

Methods {#s3}
=======

Genome Sequence Analysis {#s3a}
------------------------

*In silico* analyses were performed using SynoR (Identifying synonymous regulatory elements in vertebrate genomes), a tool described by Ovcharenko and Nobrega [@pone.0053848-Ovcharenko1]. SynoR is available at the National Center for Biotechnology Information (NCBI) DCODE.org Comparative Genomics Developments (<http://synor.dcode.org/>), and performs *de novo* identification of synonymous regulatory elements (SRE) using known patterns of transcription factor binding sites (TFBS) in active regulatory elements (RE) as seeds for genome scans. The search was performed on the human genome assembly (hg18; July 2007 NCBI Build 36.1) and compared to the mouse genome assembly (mm9; July 2007NCBI Build 37). ECBR Browser performs whole genome Blastz-based alignments using the TFBS data of the transcription factors under study from the TRANSFAC Professional database. The TFBS studied were those of CREB (CREB_01, CREBP1_01, CREBP1CJUN_01, CREB_02, CREB_Q2, CREB_Q4, CREBP1_Q2, CREB_Q3, CREB_Q2_01, CREB_Q4_01, CREBATF_Q6), MEF2 (MEF2_01, MEF2_02, MEF2_03, MEF2_04, MEF2_Q6_01) and SRF (SRF_01, SRF_Q6, SRF_C, SRF_Q4, SRF_Q5_01, SRF_Q5_02). The maximum distance between two adjacent TFBS was set at 125 base pairs. Random relative position of TFBS was allowed. To test for the significance of the results, we performed analysis of several TFBS combinations. A search for clusters combining TFBS for ZIC2, BRCA and PAX1 yields only 1 cluster indentified by SynoR, combination of ACAAT, Bach1, Lbp1 gives 50 clusters. Combination of TF related to the nervous system, EGR1, MEF2, NF-kB results on 244 clusters identified. Substitution of any of the TFBS from our particular search of MEF2, CREB and SRF significantly decreased the number of identified clusters. For example, substitution of CREB for ZIC2, i.e. search for MEF2, SRF and ZIC2 gives 142, compared to 842.

Gene Annotation and Analysis of Gene Ontolog {#s3b}
--------------------------------------------

The list of SARE genes obtained from SynoR was updated using Toppfun application from Toppgene suit Cincinnati Children's Hospital Medical Center *(* <http://toppgene.cchmc.org/> *"ToppFun")* and manually curated. A small number of genes were not annotated in NCBI but appeared annotated in other data bases (Shaded genes on STableI). GO analysis was performed using Toppfun shown in table S2. Similar significant enrichment of nervous system related functions of GO categories were obtained from the SynoR application.

Gene Expression Data Sets of Bicuculline Treatments {#s3c}
---------------------------------------------------

Experimental datasets were obtained from [@pone.0053848-Benito2]--[@pone.0053848-Bottai1] as processed datasets. Unprocessed data from [@pone.0053848-Liu1] was analyzed using GeoR2 (<http://www.ncbi.nlm.nih.gov/geo/geo2r/>). Gene annotation was updated using Toppfun application for all three datasets.

Primary Neurons Culture and Bicuculline/4-amino-pirydine Induction {#s3d}
------------------------------------------------------------------

Neurons from E18 embryo cortex were trypsinized using 0,25 µg/ml trypsin (SIGMA-Aldrich) in EBSS (Gibco, Invitrogen, Carlsbad, CA) 3.8% MgSO4 (Sigma-Aldrich, St. Louis, MO), penicillin/streptomycin (Gibco, Invitrogen, Carlsbad, CA). The reaction was stopped and cells were mechanical dissociated in EBSS media complemented with 0,26 mg/ml Trypsin inhibitor, 0,08 mg/ml DNAse, and 3,8% MgSO4 heptahydrate (all from Sigma-Aldrich, St. Louis, MO). Dissociated cells were seeded onto 24 well Poly-D-Lys (Sigma-Aldrich, St. Louis, MO) coated plates in neurobasal media supplemented with B27 complement 1×, glutamax 1× and penicillin/streptomycin (Gibco, Invitrogen, Carlsbad, CA). 500 µl media were replaced every 2 days until 16 days (DIV 16). 12 h before inducing neuronal activity cells were incubated with 2 mM tetrodotoxin (TTX) (Alomone-labs, Jerusalem, Israel). Then media was replaced with media containing with 4-aminopyridine (4AP) 100 µM, strychnine 1 µM, glycin 100 µM and bicuculline 30 µM (Sigma-Aldrich, St. Louis, MO ), and RNA was extracted after 5 h using the Qiagen RNeasy Kit as described in the manufacture handbook (Qiagen).

Luciferase Reporter Assays {#s3e}
--------------------------

Mouse genomic sequence containing SARE regulatory regions (see below) corresponding to those identified for the Cux1 and Cux2 genes were cloned into the pGL4.23 luciferase vector (Promega). The SARE sequence for Cux1 is CTGGCCGAATCTGGCTGCCTGGCGTCCTGTGAGTTAATTATAGCTCTGTTAACAGAGCAGGGAACAGGGAACACTTGCAGTGACGGAGAT. The sequence for Cux2 TTAAATAAAGCTGTCACGACTCTTCCATCAGGAGGGATGGGCTCCAAACATGAGAGTTTCCAGAGCCGTGACTATAACAGGAGTGGAAATTTATCCCTTCTAATTATGTAATTGCATAATTTTAGGTAGCATTGGAAATTATGTAA. E18,5 neuronal cells cultured for 8 days were co-transfected with the corresponding firefly luciferase reporter constructs and internal control Renilla luciferase plasmid, at a ratio of 4∶1 using lipofectamine 2000 (Invitrogen). Neuronal response was trigger using bicuculline/4-amino-pirydine as described above. Control cells Luciferase and Renilla activity was measure using the Dual-Luciferase Reporter Assay System (Promega) and following the manufacture protocol. Relative expression of each reporter construct was determined by normalizing the ratio of reporter activity to the activity on TTX treated neurons.

Q-PCR Analysis {#s3f}
--------------

1 µgr of total RNA was reverse transcribed with random primers (Invitrogen-Life Technologies, Carlsbad CA) and the superscript reverse transcriptase (New England BioLabs, Beverly, MA). PCR reaction mixtures containing DNA Master Sybr green I mix (Applied Biosystems, Foster City, CA) were incubated at 95°C for 5 min followed by 40 PCR cycles (5 s at 95°C, 45 s at 60°C, 90 s at 68°C) in an Abi-prism 7000 detector (Applied Byosystems). Primers for *Robo 1*(forward GACCTGATCGTCTCCAAAGGA; reverse TTGTCGGTCTCCACTCTTTCC); *Robo2* (forward TGATGGATCTCGTCTTCGTCA; reverse GTCGGCCCTCTGCTTTACAG); *Cux1* (forward GGGGCTTTTTATCTGCCATC; reverse CCCCCTTCCTGGTTTAAGAAG); *Cux2* (forward CTGTCCTTCATTGCACAACC; reverse TTCGGAGGTGGACTTGAAAC); *Atf3* (forward TCCTGGGTCACTGGTATTTG; reverse ATGGCGAATCTCAGCTCTTC); *Impdh2* (forward CTCCAAAGATGCCAAGAAGC; reverse TGGGAAGAGTCCAAAACCAC); *Npas4* (forward ACCTGAGCAAGGATTTGGTG; reverse TTGGTGTCAGCTGTTCTTGG); *Klf6* (forward CACCCACGACCAAATTTACC; reverse TGGAAATGACGGAGGAACTC); *Homer1-S* (forward GAAAGCTTTACCACAGGCCTAC; reverse TCAATGCTAACAGGCTCGTG); *Arc* (forward TGTTGACCGAAGTGTCCAAG; reverse AAAGACAGGCCTTGATGGAC), *Lmo4* (forward ACATTGGCACGTCCTGTTAC; reverse TCACTTGCAGGAATCGACTG) and *PlxnA4* (forward TGAGGACAACCCCAAGTGTTA; reverse ACGCGATCAGCCTGTTTTCT) were tested. The results were normalized as indicated by the parallel amplification of *β-actin* (forward GGCTGTATTCCCCTCCATCG; reverse CCAGTTGGTAACAATGCCATGT).

Statistical Analysis {#s3g}
--------------------

Probability of overlap between the FMRP target gene, and the SARE-containing gene lists was based on a binomial function, considering the size of the human genome as 28000 genes; the mouse nervous system transcriptome as 12000 transcripts and the total number of all genes associated to one or more SARE cluster is 827. We calculated the density function that describes the probability of having a number of genes within the transcriptome, with the binomial *X = B*(n~1~ = 827, p = 12/27) We then obtained the density function Y, which describes the probability of having a number of coincidences between both lists, with a new binomial (*n* = total number of FMRP targets). This probability distribution yielded a p value of 4.3909e-13 for Y(70) (for 70 coincidences). Equal analysis was performed to calculate the significance of overlapping between datasets from experimental data of bicuculline modulated genes and the SARE containing genes list.

Supporting Information {#s4}
======================

###### 

**SARE sequences conserved in human and mouse assigned to genes according to proximity.** Using SynoR, we searched for regions containing clusters of the consensus binding sequences for SRF, MEF2 and CREB in the human genome and compared it to the mouse genome to identify conserved sequences. Based on these criteria, we identified 887 genetic regions with conserved SARE sequences that are assigned to the proximal genes: 530 clusters were found on intragenic regions and 357 in intergenic, (data deposited in the SynoR tool, ID n° s1219104005847). Additional tab (OtherTFclusters) show results from the analysis of other TFBS combinations and graphics showing the relative low number of clusters identified and their lower relation to neuronal functions.

(XLSX)

###### 

Click here for additional data file.

###### 

**Gene Ontology analysis of SARE-containing genes.** GO analysis of all genes containing the SARE cluster performed by Toppfun application. Additional tab on table shows the 21 GO categories out of the total 112 enriched GO categories of biological functions related to nervous system and the same analysis performed on subsets of SARE containing genes grouped as intergenic (distant regulated genes) or intronic, promoter, CDS and utr (closely regulated genes). Most of the functions seem to be regulated by both distant and close SARE, but some of them are specific to each category (light shaded blue).

(XLSX)

###### 

Click here for additional data file.
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